FLNA (Filana Therapeutics, Inc. Common Stock) Stock Analysis

Filana Therapeutics, Inc. Common Stock (FLNA) is a publicly traded the market company. As of May 21, 2026, FLNA trades at $1.23 with a market cap of $57.49M and a P/E ratio of 0.00. FLNA moved +4.58% today. Year to date, FLNA is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $1.16 to $2.27. Rallies surfaces FLNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest FLNA stock research?

Filana Therapeutics, Inc. Common Stock (FLNA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. FLNA moved +4.58% today.

FLNA Key Metrics

Key financial metrics for FLNA
MetricValue
Price$1.23
Market Cap$57.49M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$2.27
52-Week Low$1.16
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest FLNA News

FLNA Analyst Consensus

FLNA analyst coverage data. Average price target: $0.00.

Common questions about FLNA

What can I research for FLNA on Rallies?
Filana Therapeutics, Inc. Common Stock (FLNA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. FLNA moved +4.58% today.
Does Rallies show live market data for FLNA?
Rallies combines live market context with ticker research for FLNA, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
FLNA

FLNA